Win-Partners Co Ltd
TSE:3183
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (0.4), the stock would be worth ¥1 360.96 (8% upside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.4 | ¥1 262 |
0%
|
| 3-Year Average | 0.4 | ¥1 360.96 |
+8%
|
| 5-Year Average | 0.4 | ¥1 353.42 |
+7%
|
| Industry Average | 2 | ¥6 157.35 |
+388%
|
| Country Average | 1.1 | ¥3 456.6 |
+174%
|
Forward P/S
Today’s price vs future revenue
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
Win-Partners Co Ltd
TSE:3183
|
35.1B JPY | 0.4 | 16.4 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
101.2B USD | 0.3 | 23.3 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
60.7B USD | 0.2 | 37.4 | |
| US |
|
Cencora Inc
NYSE:COR
|
60.6B USD | 0.2 | 37.3 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
47.9B USD | 0.2 | 28.8 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32B AUD | 2.8 | 35.2 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
62.8B CNY | 0.2 | 11 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.5B USD | 0.6 | 21.5 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
58.8B CNY | 1.8 | 20.7 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
58.6B HKD | 0.1 | 7.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.7 |
| Median | 1.1 |
| 70th Percentile | 1.9 |
| Max | 12 107 466 |
Other Multiples
Win-Partners Co Ltd
Glance View
WIN-Partners Co., Ltd. engages in the management of its group of companies that sell medical devices. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 547 full-time employees. The company went IPO on 2013-04-01. The firm is mainly in the provision of medical device, such as catheters used in ischemic heart disease, pacemakers used in cardiac rhythm management area, artificial blood vessels used for cardiovascular surgery area, embolization coil used in peripheral vascular disease and brain surgery, as well as the provision of large -scale medical equipment, such as computed tomography equipment (CT) used in the radiology department and the operating room.
